Pharmafile Logo

OTC Awards

- PMLiVE

FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine

Preliminary data showed a possible link between the updated vaccine and a higher risk of stroke

- PMLiVE

NICE recommends wider use of statins to cut risk of heart attack and stroke

The guidance comes after new evidence was considered on the side effects and safety of statins

- PMLiVE

World-renowned creative icon Jeremy Perrott joins KVA

KVA are excited to announce that Jeremy Perrott is joining the digital comms healthcare agency as a Board Advisor

KVA

- PMLiVE

AstraZeneca’s severe asthma treatment approved in EU for self-administration

Most healthcare providers, patients and caregivers are able to successfully use the pre-filled pen

- PMLiVE

Ipsen to acquire rare disease specialist Albireo in deal worth over $950m

The deal will strengthen the biopharma’s liver disease pipeline with the addition of Bylvay

- PMLiVE

Oramed’s oral insulin candidate fails to meet phase 3 targets

The company said it expects to end its oral insulin clinical activities for type 2 diabetes

Video: Strategic engagement case study

Supporting the launch of a global vaccine with a programme of market research and strategic insights

Inizio

- PMLiVE

Webcast: The virtual patient: How to use AI-powered conjoint to understand complex treatment decisions

Watch to find out how a combination of virtual patients and artificial intelligence can help you to better understand physicians’ decision making processes.

Inizio

Repurposing Off-Patent Drugs Through Crowd Funding

Savva Kerdemelidis, Founder & CEO of Crowd Funded Cures, explores the concepts of interventional pharmacoeconomics and pay-for-success contracts to fund new uses for off-patent drugs and other unmonopolizable therapies. 

Impetus Digital

- PMLiVE

Roche’s influenza medicine approved by EC for children

Xofluza is now the first single-dose, oral influenza medicine approved in Europe for children

- PMLiVE

AstraZeneca and Avillion’s asthma rescue treatment granted FDA approval

Airsupra significantly reduces the risk of severe asthma exacerbations

- PMLiVE

SCIRIS appoints Isaac Batley as new CEO

Batley’s healthcare communications agency was acquired by Cello in 2014

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links